Vsmall
Indicated for type 2 diabetes, utilized to target glycaemic levels and alleviate blood sugar imbalances to support long-term metabolic health.
Strengths: 50mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Galvus
- Therapeutic class
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
- Pharmacological class
Gliptin
- Contraindications
hypersensitivity to vildagliptin; severe hepatic impairment
- Precautions and warnings
monitor liver function tests; watch for symptoms of pancreatitis
- Minor side effects
dizziness; headache
- Moderate side effects
tremor; nausea; upper respiratory tract infection
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Novartis
- Onset Time
1–2 weeks
- Duration
24 hours
- Storage instructions
Store below 30°C in a dry place.
- Drug interactions
thiazides; corticosteroids
- Age restrictions
Not recommended for children.
- Pregnancy and breastfeeding
Pregnancy: Generally not recommended. Breastfeeding: Not recommended.
Serious side effects
pancreatitis — requires immediate medical attention; hepatitis — requires immediate medical attention
Patient summary
Indicated for type 2 diabetes, utilized to target glycaemic levels and alleviate blood sugar imbalances to support long-term metabolic health.
Mechanism of action
Vildagliptin is a DPP-4 inhibitor. It works by increasing the levels of incretin hormones in the body, which helps stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner, thereby stabilizing blood sugar levels.
Vsmall
Indicated for type 2 diabetes, utilized to target glycaemic levels and alleviate blood sugar imbalances to support long-term metabolic health.
Editorial Notes
- Active ingredient(s): Vildagliptin
- Listed indication(s): Type 2 Diabetes Mellitus
Available option
- 90 tablets - 50 mg1533-50-mg-18172